此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies (RWE-TDP-PRP)

2026年4月23日 更新者:ReSport Clinic

Multicenter Real-World Evidence (RWE) Study: Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies

This multicenter, prospective, observational study, based on real-world evidence (RWE), aims to evaluate the efficacy and safety of Platelet-Rich Plasma (PRP) treatment across four types of tendinopathies: patellar, Achilles, epicondylar, and plantar fasciosis. Data collection and analysis will be conducted using the BioSmartData® platform, including hematology analyzers for PRP characterization, clinical variables, treatment protocols, and longitudinal assessment of therapeutic response.

研究概览

研究类型

观察性的

注册 (估计的)

2000

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

      • A Coruña、西班牙、15009
        • 招聘中
        • Instituto Médico Arriaza
        • 接触:
          • Dr Rafael Arriaza, MD
          • 电话号码:+34 981 113 030
          • 邮箱:info@arriaza.es
      • Barcelona、西班牙、08023
        • 招聘中
        • Instituto Cugat
        • 接触:
      • Barcelona、西班牙、08029
        • 招聘中
        • ReSport Clinic
        • 接触:
      • Madrid、西班牙、28010
        • 招聘中
        • Ripoll y dePrado Medical Group
        • 接触:
      • Vitoria-Gasteiz、西班牙、01010

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

取样方法

非概率样本

研究人群

Adult patients (>18 years), of both sexes, diagnosed with patellar, Achilles, epicondylar tendinopathy or plantar fasciosis, who have received PRP treatment according to physician discretion.

描述

Inclusion Criteria:

  • Clinical and/or ultrasound diagnosis of chronic tendinopathy (duration >6 weeks)
  • Age >18 years
  • Provision of written informed consent
  • Willingness and ability to complete follow-up assessments for 12 months

Exclusion Criteria:

  • Surgical treatment of the affected tendon within the previous 6 months
  • Corticosteroid injection within the last month
  • Systemic inflammatory disease (e.g., rheumatoid arthritis)
  • Coagulopathies or ongoing anticoagulant therapy
  • Complete blood count showing a platelet concentration <100 × 10⁹/L (to exclude patients with potential thrombocytopenia)
  • Pregnancy or breastfeeding

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
干预/治疗
Patellar tendinopathy
Patellar tendinopathy treated with PRP

A minimal description of the standard PRP preparation and administration protocol will be included to document clinical variability and enable comparative analyses. Across all participating centers, the following variables will be systematically recorded:

Type of PRP used (leukocyte-rich vs. leukocyte-poor), with standardized coding

Preparation method (single vs. double centrifugation), including specification of the device used

Injected volume

Anatomical site and administration technique (ultrasound-guided whenever feasible)

Number of treatment sessions and interval between sessions

Achilles tendinopathy
Achilles tendinopathy treated with PRP

A minimal description of the standard PRP preparation and administration protocol will be included to document clinical variability and enable comparative analyses. Across all participating centers, the following variables will be systematically recorded:

Type of PRP used (leukocyte-rich vs. leukocyte-poor), with standardized coding

Preparation method (single vs. double centrifugation), including specification of the device used

Injected volume

Anatomical site and administration technique (ultrasound-guided whenever feasible)

Number of treatment sessions and interval between sessions

Plantar fasciosis
Plantar fasciosis treated with PRP

A minimal description of the standard PRP preparation and administration protocol will be included to document clinical variability and enable comparative analyses. Across all participating centers, the following variables will be systematically recorded:

Type of PRP used (leukocyte-rich vs. leukocyte-poor), with standardized coding

Preparation method (single vs. double centrifugation), including specification of the device used

Injected volume

Anatomical site and administration technique (ultrasound-guided whenever feasible)

Number of treatment sessions and interval between sessions

Chronic epycondylitis
Chronic epycondylitis treated with PRP

A minimal description of the standard PRP preparation and administration protocol will be included to document clinical variability and enable comparative analyses. Across all participating centers, the following variables will be systematically recorded:

Type of PRP used (leukocyte-rich vs. leukocyte-poor), with standardized coding

Preparation method (single vs. double centrifugation), including specification of the device used

Injected volume

Anatomical site and administration technique (ultrasound-guided whenever feasible)

Number of treatment sessions and interval between sessions

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Visual Analog Scale
大体时间:From baseline up to 12 months post-treatment
From baseline up to 12 months post-treatment
VISA-P
大体时间:baseline, 1 month, 3 months, 6 months and 12 months
Change in pain and functional limitation assessed using the Victorian Institute of Sport Assessment-Patella (VISA-P) questionnaire. Scores range from 0 to 100, with higher scores indicating better function and lower pain levels.
baseline, 1 month, 3 months, 6 months and 12 months
VISA-A
大体时间:baseline, 1 month, 3 months, 6 months and 12 months
The VISA-A is an eight item questionnaire measures Achilles tendon pain and function, with scores ranging from 0 to 100 (higher scores indicating better function).
baseline, 1 month, 3 months, 6 months and 12 months
Patient Rated Tennis Elbow Evaluation Scale
大体时间:baseline, 1 month, 3 months, 6 months and 12 months
The Patient-Rated Tennis Elbow Evaluation (PRTEE) is a 15-item self-report questionnaire designed to measure pain and functional disability in patients with lateral epicondylitis (tennis elbow). It includes a 5-item pain subscale and a 10-item function subscale, providing a total score out of 100 to assess, evaluate, and monitor recovery.
baseline, 1 month, 3 months, 6 months and 12 months
Foot Function Index
大体时间:baseline, 1 month, 3 months, 6 months and 12 months
The Foot Function Index (FFI) is a 23-item, self-administered questionnaire designed to measure the impact of foot pathology on function, assessing pain, disability, and activity limitation. It uses a 0-10 Likert scale for items within three subscales, with higher total percentages (0-100%) indicating greater, more severe pain and dysfunction.
baseline, 1 month, 3 months, 6 months and 12 months

次要结果测量

结果测量
措施说明
大体时间
Predictive factors of response to PRP treatment
大体时间:baseline
Identify clinical patterns predictive of better PRP treatment response using multivariate analysis and artificial intelligence
baseline
Adverse events
大体时间:1 month, 3 months, 6 months, 12 months
Assess the incidence of local or systemic adverse events following PRP administration
1 month, 3 months, 6 months, 12 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

合作者

调查人员

  • 首席研究员:Ferran Abat Gonzalez, MD PhD、ReSport Clinic

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年4月1日

初级完成 (估计的)

2028年3月1日

研究完成 (估计的)

2028年3月1日

研究注册日期

首次提交

2026年4月23日

首先提交符合 QC 标准的

2026年4月23日

首次发布 (实际的)

2026年4月30日

研究记录更新

最后更新发布 (实际的)

2026年4月30日

上次提交的符合 QC 标准的更新

2026年4月23日

最后验证

2026年4月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅